Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Engelhardt

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|January 3, 2006
Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methodsRainer Hoffmann, Stephan von Bardeleben, Jaroslaw D Kasprzak, et al.
British Journal of Cancer|August 2, 2018
Detection of circulating tumour cell clusters in human glioblastomaIlona Krol, Francesc Castro-Giner, Martina Maurer, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trialHeidi Segers, Jaime G Deville, William J Muller, et al.
Neuro-Oncology Advances|October 7, 2024
Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastomaMatthias Holdhoff, Xiaobu Ye, Roy E Strowd, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2018
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE TrialBart Jan Kullberg, Claudio Viscoli, Peter G Pappas, et al.
JNCI Cancer Spectrum|April 16, 2024
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrationsAndrea Necchi, Rodryg Ramlau, Alejandro Falcón González, et al.
The New England Journal of Medicine|September 27, 2023
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> BacteremiaThomas L Holland, Sara E Cosgrove, Sarah B Doernberg, et al.
British Journal of Cancer|August 4, 2020
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumoursRebecca Kristeleit, Jeffry Evans, L Rhoda Molife, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|January 3, 2006
Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methodsRainer Hoffmann, Stephan von Bardeleben, Jaroslaw D Kasprzak, et al.
British Journal of Cancer|August 2, 2018
Detection of circulating tumour cell clusters in human glioblastomaIlona Krol, Francesc Castro-Giner, Martina Maurer, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2024
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trialHeidi Segers, Jaime G Deville, William J Muller, et al.
Neuro-Oncology Advances|October 7, 2024
Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastomaMatthias Holdhoff, Xiaobu Ye, Roy E Strowd, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2018
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE TrialBart Jan Kullberg, Claudio Viscoli, Peter G Pappas, et al.
JNCI Cancer Spectrum|April 16, 2024
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrationsAndrea Necchi, Rodryg Ramlau, Alejandro Falcón González, et al.
The New England Journal of Medicine|September 27, 2023
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> BacteremiaThomas L Holland, Sara E Cosgrove, Sarah B Doernberg, et al.
British Journal of Cancer|August 4, 2020
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumoursRebecca Kristeleit, Jeffry Evans, L Rhoda Molife, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical TrialsEmmanuel Weiss, Jean-Ralph Zahar, Jeff Alder, et al.
Pageof 5